ArticleSignal transduction and targeted therapy2026
Engineering an AIEgen-based platform integrating CRISPR/Cas9 to remodel the tumor microenvironment and reinforce photo-immunotherapy against glioblastom.
Guanghong Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.